Gagnon Securities LLC decreased its holdings in Celcuity Inc. (NASDAQ:CELC – Get Rating) by 33.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 54,655 shares of the company’s stock after selling 26,998 shares during the period. Gagnon Securities LLC owned 0.35% […]
Celcuity (NASDAQ:CELC – Get Rating) and Aclarion (NASDAQ:ACON – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability. Earnings and Valuation This table compares Celcuity and Aclarion’s revenue, earnings […]
Gedatolisib demonstrated superior anti-proliferative potency and efficacy in endometrial, ovarian and cervical cancer cell lines compared to other PAM inhibitors evaluated regardless of PTEN, P13K, or